Monocyte and Lymphocyte Count, and Lymphocyte/Monocyte Ratio as Prognostic Factors at the Time of First Relapse in Canine Diffuse Large B-Cell Lymphoma Patients Receiving Chemotherapy
Absolute monocyte and lymphocyte counts and LMR at the time of relapse were not found to be prognostic indicators of OS<sub>r</sub> in this population of dogs with multicentric lymphoma. Additional studies evaluating absolute monocyte and lymphocyte counts during chemotherapy treatment and following completion of chemotherapy in larger population of dogs are needed to assess whether these counts have clinical utility in detecting disease progression.
Authors
- Alenka Lavra Zajc (ORCID: https://orcid.org/0000-0002-8205-2239)
- C Molina (ORCID: https://orcid.org/0000-0003-4985-7294)
- Adam Swallow (ORCID: https://orcid.org/0000-0002-3609-3830)
- Teresa N. Sparks (ORCID: https://orcid.org/0000-0002-8593-2186)
- Sara Cermeno (ORCID: https://orcid.org/0000-0002-4052-5720)
Institutions
- Royal North Shore Hospital (AU)
- Social Insurance Institute (GR)
- UK Health and Environment Research Institute (GB)
- Northwest Orthopaedic Specialists (US)
Publication Details
- Journal
- Animals
- Published
- 2025-12-19
- DOI
- https://doi.org/10.3390/ani16010009
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00